Total Payments
$7,686
2024 Payments
$141.46
Companies
12
Transactions
17
Medicare Patients
9,156
Medicare Billing
$1.1M
Payment Breakdown by Category
Consulting$6,450 (83.9%)
Food & Beverage$1,236 (16.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,450 | 1 | 83.9% |
| Food and Beverage | $1,236 | 16 | 16.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $6,450 | 1 | $0 (2017) |
| Genentech, Inc. | $337.21 | 4 | $0 (2022) |
| Mallinckrodt LLC | $238.80 | 2 | $0 (2018) |
| Alcon Laboratories Inc | $184.69 | 1 | $0 (2018) |
| Apellis Pharmaceuticals, Inc. | $130.95 | 1 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $86.03 | 1 | $0 (2024) |
| Biogen, Inc. | $71.58 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $46.79 | 1 | $0 (2018) |
| Alcon Vision LLC | $42.37 | 2 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $34.75 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.46 | 3 | Regeneron Pharmaceuticals, Inc. ($86.03) |
| 2023 | $159.44 | 2 | Apellis Pharmaceuticals, Inc. ($130.95) |
| 2022 | $341.33 | 5 | Genentech, Inc. ($213.61) |
| 2019 | $101.60 | 1 | Genentech, Inc. ($101.60) |
| 2018 | $355.04 | 3 | Alcon Laboratories Inc ($184.69) |
| 2017 | $6,587 | 3 | Merck Sharp & Dohme Corporation ($6,450) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $86.03 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/05/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 02/05/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Ophthalmology | ||||||
| 09/15/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/13/2023 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $130.95 | General |
| 12/13/2022 | Genentech, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $94.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/11/2022 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 06/28/2022 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $71.58 | General |
| 03/22/2022 | Genentech, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $119.53 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/23/2022 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Ophthalmology | ||||||
| 06/10/2019 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $101.60 | General |
| Category: Ophthalmology | ||||||
| 11/26/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $123.56 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 07/26/2018 | Novartis Pharmaceuticals Corporation | BROLUCIZUMAB (Drug) | Food and Beverage | In-kind items and services | $46.79 | General |
| 04/09/2018 | Alcon Laboratories Inc | Constellation (Device) | Food and Beverage | In-kind items and services | $184.69 | General |
| Category: Ophthalmology | ||||||
| 12/11/2017 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $115.24 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 09/11/2017 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Ophthalmology | ||||||
| 08/30/2017 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $6,450.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,227 | 4,225 | $1.9M | $274,167 |
| 2022 | 15 | 2,460 | 4,618 | $1.8M | $277,538 |
| 2021 | 15 | 2,415 | 4,683 | $1.8M | $296,494 |
| 2020 | 14 | 2,054 | 4,066 | $1.6M | $254,885 |
Total Patients
9,156
Total Services
17,592
Medicare Billing
$1.1M
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67028 | Injection of drug into eye | Office | 2023 | 189 | 892 | $1.1M | $85,187 | 7.5% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 641 | 860 | $204,714 | $56,315 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 277 | 608 | $72,328 | $51,984 | 71.9% |
| 92134 | Imaging of retina | Office | 2023 | 872 | 1,599 | $122,724 | $35,892 | 29.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 23 | 31 | $160,146 | $15,992 | 10.0% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 12 | 12 | $122,472 | $12,714 | 10.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 63 | 63 | $19,100 | $4,938 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $6,006 | $3,958 | 65.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 11 | 12 | $13,662 | $3,695 | 27.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 45 | 50 | $13,095 | $1,918 | 14.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 28 | 29 | $3,942 | $800.80 | 20.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 19 | 21 | $1,564 | $420.21 | 26.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 14 | 15 | $2,787 | $352.52 | 12.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 223 | 1,044 | $1.1M | $90,717 | 8.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 355 | 692 | $78,328 | $54,491 | 69.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 596 | 811 | $193,093 | $52,018 | 26.9% |
| 92134 | Imaging of retina | Office | 2022 | 913 | 1,665 | $102,798 | $36,072 | 35.1% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 18 | 18 | $116,298 | $11,755 | 10.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 23 | 26 | $134,316 | $11,490 | 8.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 73 | 73 | $21,462 | $5,024 | 23.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 16 | 18 | $18,672 | $4,783 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $10,482 | $4,736 | 45.2% |
| 67028 | Injection of drug into eye | Facility | 2022 | 15 | 25 | $34,437 | $1,595 | 4.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 36 | 42 | $9,117 | $1,561 | 17.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 34 | 34 | $3,696 | $849.39 | 23.0% |
About Dr. Steven Sanislo, MD
Dr. Steven Sanislo, MD is a Retina Specialist healthcare provider based in Stanford, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356409882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Sanislo, MD has received a total of $7,686 in payments from pharmaceutical and medical device companies, with $141.46 received in 2024. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($6,450).
As a Medicare-enrolled provider, Sanislo has provided services to 9,156 Medicare beneficiaries, totaling 17,592 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Stanford, CA
- Active Since 12/05/2006
- Last Updated 04/04/2024
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1356409882
Products in Payments
- ACTHAR (Biological) $238.80
- Constellation (Device) $227.06
- VABYSMO (Drug) $213.61
- Lucentis (Biological) $123.60
- EYLEA (Biological) $86.03
- BROLUCIZUMAB (Drug) $46.79
- YUTIQ (Drug) $34.75
- DEXTENZA (Drug) $34.45
- Vabysmo (Drug) $28.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.